1393352-93-6

Basic information

• Product Name: N-((6-(benzyloxy)quinolin-3-yl)methyl)-N-ethylethanamine
• Synonyms: N-((6-(benzyloxy)quinolin-3-yl)methyl)-N-ethylethanamine
• CAS NO: 1393352-93-6
• Molecular Weight: 320.434
• Mol File: 1393352-93-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-((6-(benzyloxy)quinolin-3-yl)methyl)-N-ethylethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-((6-(benzyloxy)quinolin-3-yl)methyl)-N-ethylethanamine(1393352-93-6)
• EPA Substance Registry System: N-((6-(benzyloxy)quinolin-3-yl)methyl)-N-ethylethanamine(1393352-93-6)

Safety Data

• Hazardous Substances Data: 1393352-93-6(Hazardous Substances Data)

Upstream product

• 1337882-50-4 6-(benzyloxy)-3-bromoquinoline 
• 1022151-47-8 3-bromoquinolin-6-yl acetate 
• 24306-33-0 methyl quinolin-6-ylethanoate 
• 13669-57-3 3-bromo-6-hydroxyquinoline 
• 580-16-5 6-hydroxyquinoline 
• 100-39-0 benzyl bromide 

Relevant articles and documents

[1,2,4] TRIAZOLO [4,3-B] PYRIDAZINE COMPOUNDS AS INHIBITORS OF THE C-MET TYROSINE KINASE

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).